Spots Global Cancer Trial Database for endometrial neoplasms
Every month we try and update this database with for endometrial neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma | NCT02387645 | Cancer of Endom... Carcinoma of En... Endometrial Neo... | Lavage of the U... | 18 Years - 80 Years | Medical University of Vienna | |
| Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study | NCT04865289 | Endometrial Neo... | Lenvatinib Pembrolizumab Paclitaxel Carboplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Endometrial Malignancy in Breast Cancer Patients With or Without AUB | NCT05977829 | Endometrial Neo... | Ultrasound Hysteroscopy | 43 Years - 70 Years | University of Campania "Luigi Vanvitelli" | |
| Registry Platform Ovarian and Endometrial Cancer | NCT05129969 | Ovarian Cancer Endometrial Can... Ovary Neoplasm Endometrial Neo... Carcinoma, Ovar... Carcinoma Neoplasm, Ovari... | Physician's cho... | 18 Years - | iOMEDICO AG | |
| Registry Platform Ovarian and Endometrial Cancer | NCT05129969 | Ovarian Cancer Endometrial Can... Ovary Neoplasm Endometrial Neo... Carcinoma, Ovar... Carcinoma Neoplasm, Ovari... | Physician's cho... | 18 Years - | iOMEDICO AG | |
| Diet and Physical Activity in Uterine Cancer Survivors | NCT02433080 | Endometrial Neo... | Shape-Up follow... | 18 Years - | University College, London | |
| A Study of LY4170156 in Participants With Selected Advanced Solid Tumors | NCT06400472 | Ovarian Neoplas... Endometrial Neo... Uterine Cervica... Carcinoma, Non-... Triple Negative... Pancreatic Neop... Colorectal Neop... | LY4170156 | 18 Years - | Eli Lilly and Company | |
| STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer | NCT02676726 | Endometrial Neo... Ovarian Neoplas... | Extraperitoneal... Transperitoneal... | 18 Years - 85 Years | Hospital Universitari Vall d'Hebron Research Institute | |
| Survival Outcomes of Uterine Malignancies in Chinese Population | NCT03291275 | Endometrial Neo... Survival | Follow-up for d... | - | Peking Union Medical College Hospital | |
| Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) | NCT04976634 | Carcinoma, Hepa... Colorectal Neop... Pancreatic Duct... Biliary Tract N... Endometrial Neo... Esophageal Neop... | Pembrolizumab Belzutifan Lenvatinib | 18 Years - | Merck Sharp & Dohme LLC | |
| Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure | NCT06171581 | Biopsy Wound Endometrial Hyp... Endometrial Neo... | stress ball control | 18 Years - | Zonguldak Bulent Ecevit University | |
| POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation | NCT06409039 | Endometrial Neo... | 18 Years - | Azienda Ulss 2 Marca Trevigiana | ||
| Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study | NCT05657483 | Endometrial Neo... Inflammatory Re... | Venous blood sa... Surgical stagin... | 18 Years - | University of Campania "Luigi Vanvitelli" | |
| Questionnaire Study for Gynecological Cancer Survivors | NCT00391664 | Endometrial Neo... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Genital Neoplas... | Psychosocial | 20 Years - 75 Years | Walter Reed Army Medical Center | |
| Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? | NCT03207126 | Endometrial Can... Endometrial Neo... Endometrial Hyp... Endometrial Pol... | Ultrasound guid... | 18 Years - | Imperial College London | |
| Early Detection of Cancers in Low Resource Countries | NCT01178736 | Breast Neoplasm... Uterine Cervica... Ovarian Neoplas... Endometrial Neo... | Breast Cancer S... Cervical Cancer... Ovarian Cancer ... Endometrial Can... | 30 Years - 64 Years | Woman's Cancer Foundation | |
| Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) | NCT03517449 | Endometrial Neo... | Pembrolizumab Lenvatinib Paclitaxel Doxorubicin | 18 Years - | Eisai Inc. | |
| Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma | NCT00050440 | Endometrial Neo... Uterine Neoplas... Genital Neoplas... | Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Molecular Markers in Treatment in Endometrial Cancer | NCT00598845 | Endometrial Neo... Neoplasm Metast... | Tumor biopsy st... | - | University of Bergen | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer | NCT03276013 | Endometrial Neo... | Pembrolizumab | 18 Years - | Vall d'Hebron Institute of Oncology | |
| A Study of SGN-B7H4V in Advanced Solid Tumors | NCT05194072 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... Triple Negative... HER2 Negative B... Hormone Recepto... Endometrial Neo... Carcinoma, Non-... Cholangiocarcin... Gallbladder Car... Adenoid Cystic ... | SGN-B7H4V | 18 Years - | Seagen Inc. | |
| Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer | NCT03291106 | Colorectal Neop... Endometrial Neo... | immunohistochem... tests of micros... clinical criter... sequencing for ... | 18 Years - | Peking Union Medical College Hospital | |
| A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 | NCT06003231 | Carcinoma, Squa... Carcinoma, Non-... Ovarian Neoplas... Endometrial Neo... | disitamab vedot... | 18 Years - | Seagen Inc. | |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] | NCT03555422 | Endometrial Can... | Selinexor Matching placeb... | 18 Years - | Karyopharm Therapeutics Inc | |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] | NCT03555422 | Endometrial Can... | Selinexor Matching placeb... | 18 Years - | Karyopharm Therapeutics Inc | |
| Sentinel Node and Endometrial Cancer | NCT00987051 | Endometrial Neo... | Detection of se... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| A Study of SGN-STNV in Advanced Solid Tumors | NCT04665921 | Carcinoma, Non-... HER2 Negative B... Ovarian Neoplas... Uterine Cervica... Endometrial Neo... Esophageal Neop... Gastroesophagea... Stomach Neoplas... Colorectal Neop... Exocrine Pancre... Appendiceal Ade... Pseudomyxoma Pe... | SGN-STNV | 18 Years - | Seagen Inc. | |
| Robotic Versus Abdominal Surgery for Endometrial Cancer | NCT01847703 | Endometrial Neo... | Robotic surgery Abdominal surge... | 18 Years - 75 Years | Karolinska Institutet | |
| Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) | NCT03884101 | Endometrial Neo... | Lenvatinib Pembrolizumab Paclitaxel Carboplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Lenvatinib in Second Line Endometrial Carcinoma | NCT03005015 | Endometrial Neo... | Lenvatinib Doxorubicin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy. | NCT04063072 | Uterine Neoplas... | ERAS protocol | 18 Years - | Ospedale Regina Montis Regalis | |
| Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer | NCT02564276 | Endometrial Neo... | Sentinel lymph ... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| A Study of DB-1303 in Advanced/Metastatic Solid Tumors | NCT05150691 | HER2-positive A... | DB-1303 Pertuzumab Inje... Ritonavir Itraconazole | 18 Years - | DualityBio Inc. | |
| Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | NCT03543215 | Endometrial Can... Endometrial Neo... | Radiomics: Anal... | 18 Years - | Imperial College London | |
| Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) | NCT03884101 | Endometrial Neo... | Lenvatinib Pembrolizumab Paclitaxel Carboplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer | NCT06363708 | Endometrial Neo... | Tislelizumab Paclitaxel Carboplatin | 18 Years - | Zhongnan Hospital | |
| [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers | NCT01717391 | Uterine Cervica... Endometrial Neo... Anus Neoplasms Rectal Neoplasm... Prostatic Neopl... | fluorothymidine... | 18 Years - | University of Iowa | |
| Pre-Clinical Models in Gynecological Tumors A Tissue Repository | NCT00250783 | Endometrial Neo... Uterine Neoplas... | 18 Years - | University of New Mexico | ||
| Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? | NCT03543215 | Endometrial Can... Endometrial Neo... | Radiomics: Anal... | 18 Years - | Imperial College London | |
| Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma | NCT01888562 | Endometrial Neo... | Ponatinib | 18 Years - | Washington University School of Medicine | |
| Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer | NCT05682950 | Uterine Cervica... Endometrial Neo... | online adaptive... | 18 Years - 70 Years | Peking Union Medical College Hospital | |
| GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients | NCT05316935 | Endometrial Neo... Atypical Endome... Progesterone Re... | GnRHa Letrozole 2.5mg Diane-35 MET | 18 Years - 45 Years | Fudan University | |
| HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding | NCT04867109 | Endometrial Neo... Postmenopause Uterine Hemorrh... Cancer Biomarke... CA 125 Antigen | Patients with P... CA125 and HE4 a... | 18 Years - | Nantes University Hospital | |
| Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] | NCT03555422 | Endometrial Can... | Selinexor Matching placeb... | 18 Years - | Karyopharm Therapeutics Inc | |
| A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) | NCT06023862 | Ovarian Neoplas... Endometrial Neo... Uterine Cervica... Vulvar Cancer Vagina Neoplasm Clear Cell Carc... | Dostarlimab Bevacizumab Doxorubicin Gemcitabine Paclitaxel Pegylated lipos... | 18 Years - | Yonsei University | |
| Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) | NCT04956640 | Carcinoma, Non-... Colorectal Neop... Endometrial Neo... Ovarian Neoplas... Pancreatic Neop... Biliary Tract N... | LY3537982 Pembrolizumab Cetuximab Pemetrexed Cisplatin Carboplatin | 18 Years - | Eli Lilly and Company | |
| Early Detection of Cancers in Low Resource Countries | NCT01178736 | Breast Neoplasm... Uterine Cervica... Ovarian Neoplas... Endometrial Neo... | Breast Cancer S... Cervical Cancer... Ovarian Cancer ... Endometrial Can... | 30 Years - 64 Years | Woman's Cancer Foundation | |
| Robotic Versus Abdominal Surgery for Endometrial Cancer | NCT01847703 | Endometrial Neo... | Robotic surgery Abdominal surge... | 18 Years - 75 Years | Karolinska Institutet | |
| Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) | NCT05795244 | Endometrial Neo... Endometrial Can... | Nivolumab | 20 Years - | Yonsei University | |
| Survival Outcomes of Uterine Malignancies in Chinese Population | NCT03291275 | Endometrial Neo... Survival | Follow-up for d... | - | Peking Union Medical College Hospital | |
| A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer | NCT01654458 | Sexual Dysfunct... Uterine Cervica... Ovarian Neoplas... Uterine Neoplas... Genital Neoplas... | GyneGals Suppor... | 18 Years - | Women's College Hospital | |
| Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) | NCT03517449 | Endometrial Neo... | Pembrolizumab Lenvatinib Paclitaxel Doxorubicin | 18 Years - | Eisai Inc. | |
| Lenvatinib in Second Line Endometrial Carcinoma | NCT03005015 | Endometrial Neo... | Lenvatinib Doxorubicin | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Sleep and Endometrial Cancer | NCT00936598 | Sleep Endometrial Neo... Pain | zolpidem sugar pill | 18 Years - | University of Pittsburgh | |
| Endometrial Lesions Predictions | NCT05588076 | Endometrial Neo... | no intervention | 18 Years - 60 Years | Beijing Friendship Hospital | |
| A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) | NCT06023862 | Ovarian Neoplas... Endometrial Neo... Uterine Cervica... Vulvar Cancer Vagina Neoplasm Clear Cell Carc... | Dostarlimab Bevacizumab Doxorubicin Gemcitabine Paclitaxel Pegylated lipos... | 18 Years - | Yonsei University | |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer | NCT00377520 | Neoplasms Neoplasms by Si... Urogenital Neop... Genital Neoplas... Uterine Neoplas... Endometrial Neo... Cancer of Endom... Endometrial Can... Cancer of the E... Endometrium Can... Neoplasms, Endo... | pemetrexed | - | Eli Lilly and Company | |
| The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma | NCT01820858 | Endometrial Neo... | Paclitaxel Paraplatin (Car... Pelvic Radiatio... Vaginal Brachyt... Vaginal brachyt... | 18 Years - 65 Years | Huazhong University of Science and Technology | |
| Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) | NCT04956640 | Carcinoma, Non-... Colorectal Neop... Endometrial Neo... Ovarian Neoplas... Pancreatic Neop... Biliary Tract N... | LY3537982 Pembrolizumab Cetuximab Pemetrexed Cisplatin Carboplatin | 18 Years - | Eli Lilly and Company | |
| Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer | NCT03291106 | Colorectal Neop... Endometrial Neo... | immunohistochem... tests of micros... clinical criter... sequencing for ... | 18 Years - | Peking Union Medical College Hospital | |
| Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors | NCT03935282 | Breast Neoplasm Prostatic Neopl... Colorectal Neop... Endometrial Neo... Hodgkin Disease Non Hodgkin Lym... | AH-HA Tool in t... | 18 Years - | Wake Forest University Health Sciences | |
| Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology | NCT01969396 | Menorrhagia Endometrial Neo... Polycystic Ovar... Uterine Neoplas... | SonoBiopsy Cath... Endometrial bio... | 18 Years - | Cook Group Incorporated | |
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | NCT03000192 | Breast Cancer F... Breast Neoplasm Non-Hodgkin's B... Non-Hodgkin's L... NonHodgkin Lymp... Diffuse Large B... Diffuse Large C... Ovarian Cancer Ovarian Neoplas... Endometrial Can... Endometrial Neo... Cervical Cancer Cervical Neopla... Primary Periton... Fallopian Tube ... Fallopian Tube ... Vulvar Cancer Vulvar Neoplasm... | 16 Years - | University Hospital Southampton NHS Foundation Trust | ||
| Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) | NCT04634877 | Endometrial Neo... | Pembrolizumab Carboplatin Paclitaxel Placebo for pem... Docetaxel Cisplatin External Beam R... Cisplatin (as r... Brachytherapy | 18 Years - | Merck Sharp & Dohme LLC | |
| Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) | NCT03884101 | Endometrial Neo... | Lenvatinib Pembrolizumab Paclitaxel Carboplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer | NCT02494791 | Lynch Syndrome Endometrial Neo... Ovarian Neoplas... Colorectal Neop... | Questionnaire, ... | 18 Years - 70 Years | University Health Network, Toronto | |
| A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients | NCT05375136 | Endometrial Neo... Endometrium Carcinoma Renal Cell Carc... | Non-interventio... | 18 Years - | Eisai Inc. | |
| STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Cancer | NCT01810874 | Endometrial Neo... Ovarian Neoplas... | Transperitoneal... Extraperitoneal... | - | Hospital Universitari Vall d'Hebron Research Institute | |
| Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications | NCT02865889 | UTERINE CERVICA... ENDOMETRIAL NEO... | Laparoscopy in ... Conventional su... | 18 Years - | Institut Paoli-Calmettes | |
| Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique | NCT03766672 | Endometrial Neo... | Intervention Ar... | - | University Hospital Center of Martinique | |
| Endometrial Malignancy in Breast Cancer Patients With or Without AUB | NCT05977829 | Endometrial Neo... | Ultrasound Hysteroscopy | 43 Years - 70 Years | University of Campania "Luigi Vanvitelli" | |
| Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? | NCT03207126 | Endometrial Can... Endometrial Neo... Endometrial Hyp... Endometrial Pol... | Ultrasound guid... | 18 Years - | Imperial College London | |
| Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy | NCT05793749 | Uterine Cervica... Endometrial Neo... Lymphedema Treatment Effec... | Prophylactic ly... | 18 Years - 60 Years | Chongqing University Cancer Hospital | |
| Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? | NCT03207061 | Endometrial Can... Endometrial Neo... Endometrial Hyp... | 3D Ultrasound | 18 Years - | Imperial College London | |
| A Study of SGN-ALPV in Advanced Solid Tumors | NCT05229900 | Ovarian Neoplas... Endometrial Neo... Carcinoma, Non-... Stomach Neoplas... Gastroesophagea... Uterine Cervica... Testicular Neop... | SGN-ALPV | 18 Years - | Seagen Inc. | |
| Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma | NCT01460979 | Genital Disease... Ovarian Disease... Ovarian Neoplas... Endometrial Neo... | Temsirolimus | 18 Years - | AGO Study Group | |
| Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? | NCT03570437 | Carcinosarcoma Endometrial Neo... | Paclitaxel Cediranib Olaparib | 16 Years - | University of Manchester | |
| Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma | NCT01888562 | Endometrial Neo... | Ponatinib | 18 Years - | Washington University School of Medicine | |
| Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer | NCT05869123 | Uterine Cervica... Endometrial Neo... | Online adaptive... | 18 Years - 70 Years | Peking Union Medical College Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
